Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice

• Published in: Biological & pharmaceutical bulletin 2018/07/01, Vol.41(7), pp.1078-1083
• Main Authors: Emam, Sherif E., Ando, Hidenori, Lila, Amr Selim Abu, Kobayashi, Shinya, Shimizu, Taro, Okuhira, Keiichiro, Ishima, Yu, Ishida, Tatsuhiro
• Format: Article
• Language: English
• Subjects: Antineoplastic drugs; Antitumor activity; Antitumor agents; Cancer; CD63 antigen; CD9 antigen; chemotherapeutic agent; Chemotherapy; Doxorubicin; exosome; Exosomes; Immunosuppressive agents; Injection; Intravenous administration; liposomal doxorubicin; Mice; Secretions; Size distribution; Spleen; Splenectomy; Vesicles
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.b18-00202

Modulation of tumor immunity is a known factor in the antitumor activity of many chemotherapeutic agents. Exosomes are extracellular nanometric vesicles that are released by almost all types of cells, which includes cancer cells. These vesicles play a crucial role in tumor immunity. Many in vitro studies have reproduced the aggressive secretion of exosomes following treatment with conventional anticancer drugs. Nevertheless, how chemotherapeutic agents including nanomedicines such as Doxil® affect the in vivo secretion of exosomes is yet to be elucidated. In this study, the effect of intravenous injection of either free doxorubicin (DXR) or liposomal DXR formulation (Doxil®) on exosome secretion was evaluated in BALB/c mice. Exosomes were isolated from serum by using an ExoQuick™ kit. Free DXR treatment markedly increased serum exosome levels in a post-injection time-dependent manner, while Doxil® treatment did not. Exosomal size distribution and marker protein expressions (CD9, CD63, and TSG101) were studied. The physical/biological characteristics of treatment-induced exosomes were comparable to those of control mice. Interestingly, splenectomy significantly suppressed the copious exosomal secretions induced by free DXR. Collectively, our results indicate that conventional anticancer agents induce the secretion of circulating exosomes, presumably via stimulating immune cells of the spleen. As far as we know, this study represents the first report indicating that conventional chemotherapeutics may induce exosome secretion which might, in turn, contribute partly to the antitumor effect of chemotherapeutic agents.